Anlon Healthcare Limited
Promoter holding in Anlon Healthcare Limited has stayed unchanged at 52.68% for the last 5 quarters on record (since Jun 2025).
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 52.68%=0.00 | 47.32%=0.00 |
| Mar '26 | 52.68%=0.00 | 47.32%=0.00 |
| Dec '25 | 52.68%=0.00 | 47.32%=0.00 |
| Sep '25 | 52.68%=0.00 | 47.32%=0.00 |
| Jun '25 | 52.68% | 47.32% |
Compared with similar companies
Promoter holding in Anlon Healthcare Limited is lower than 51% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Anlon Healthcare Limited | 52.68% |
| Fermenta Biotech Limited | 64.09% |
| Kopran Limited | 44.42% |
| Shalby Limited | 74.33% |
| Bharat Parenterals Limited | 67.20% |
| Jagsonpal Pharmaceuticals Limited | 69.05% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Anlon Healthcare Limited's promoter holding?
Promoters held 52.68% of Anlon Healthcare Limited as of 30 Jun 2026, and the public held 47.32%.
Has Anlon Healthcare Limited's promoter holding increased?
No, it was unchanged in the quarter to Jun 2026.
Are any promoter shares of Anlon Healthcare Limited pledged?
No promoter shares are recorded as pledged.
How does Anlon Healthcare Limited's promoter holding compare with similar companies?
Promoter holding in Anlon Healthcare Limited is lower than 51% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.